Predicting Tumor Mutational Burden From Lung Adenocarcinoma Histopathological Images Using Deep Learning

Tumor mutation burden (TMB) is an important biomarker for tumor immunotherapy. It plays an important role in the clinical treatment process, but the gold standard measurement of TMB is based on whole exome sequencing (WES). WES cannot be done in most hospitals due to its high cost, long turnaround t...

Descripción completa

Detalles Bibliográficos
Autores principales: Niu, Yi, Wang, Lixia, Zhang, Xiaojie, Han, Yu, Yang, Chunjie, Bai, Henan, Huang, Kaimei, Ren, Changjing, Tian, Geng, Yin, Shengjie, Zhao, Yan, Wang, Ying, Shi, Xiaoli, Zhang, Minghui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213738/
https://www.ncbi.nlm.nih.gov/pubmed/35756617
http://dx.doi.org/10.3389/fonc.2022.927426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213738/
https://www.ncbi.nlm.nih.gov/pubmed/35756617
http://dx.doi.org/10.3389/fonc.2022.927426

Ejemplares similares